PUBLISHER: Acute Market Reports | PRODUCT CODE: 1517825
PUBLISHER: Acute Market Reports | PRODUCT CODE: 1517825
Breast Cancer Core Needle Biopsy Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
The breast cancer core needle biopsy market refers to the sector focused on the use of core needle biopsy techniques for diagnosing breast cancer. This method involves the use of a hollow needle to extract a small cylinder of tissue (a core) from a suspicious area within the breast to be examined for cancer cells. Breast cancer core needle biopsy market is estimated to grow at a CAGR of 4.7% from 2024 to 2032. Core needle biopsies are highly valued for their accuracy in diagnosing breast cancer. Unlike fine-needle aspirations which may not gather enough cells for a conclusive diagnosis, core needle biopsies provide a larger tissue sample, enabling pathologists to make a more definitive diagnosis.
Driver: Increasing Prevalence of Breast Cancer
The primary driver for the growth of the breast cancer core needle biopsy market is the increasing prevalence of breast cancer globally. Breast cancer remains one of the most common cancers among women worldwide, with incidence rates continuing to rise. This increase is attributed to various factors such as aging populations, changes in reproductive patterns, and lifestyle factors. As the number of breast cancer cases escalates, the need for early and accurate diagnosis becomes more critical. Core needle biopsy, being a reliable and minimally invasive diagnostic procedure, is increasingly preferred by healthcare professionals for initial cancer diagnosis. This preference is due to its ability to provide a substantial amount of tissue for histopathological examination, leading to a more accurate diagnosis compared to fine-needle aspirations. Moreover, the growing awareness and emphasis on early cancer detection and screening programs have significantly contributed to the increased demand for core needle biopsies. Regular screening and early detection efforts are crucial in improving breast cancer outcomes, thereby driving the demand for effective diagnostic procedures like core needle biopsy.
Opportunity: Technological Advancements in Biopsy Techniques
The market presents a significant opportunity in the realm of technological advancements in biopsy techniques. Innovations in core needle biopsy devices, including automated and vacuum-assisted needles, have enhanced the precision and efficiency of the procedure. These technological advancements not only improve the accuracy of cancer diagnosis but also reduce patient discomfort and procedure time. The integration of core needle biopsy with advanced imaging techniques like 3D mammography and MRI further augments the accuracy of the procedure, especially in detecting and sampling non-palpable lesions. This integration is particularly crucial in cases where abnormalities are detected through screening before they are physically noticeable. The ongoing development in biopsy devices, focusing on improving patient comfort and diagnostic accuracy, presents a substantial growth opportunity for the market. As healthcare continues to move towards more patient-centered and less invasive procedures, the demand for advanced core needle biopsy techniques is expected to rise.
Restraint: High Cost and Limited Accessibility
A significant restraint in the breast cancer core needle biopsy market is the high cost and limited accessibility of the procedure in certain regions. The cost of core needle biopsy, especially when combined with advanced imaging guidance, can be prohibitive for patients without adequate health insurance or those in low-income regions. This cost factor limits the accessibility of this crucial diagnostic tool, leading to disparities in breast cancer diagnosis and treatment. In developing countries, where healthcare resources are often limited, the availability of advanced biopsy techniques and trained professionals is not widespread. This lack of accessibility is compounded by a general absence of awareness and organized breast cancer screening programs in these regions. Consequently, many patients in low-resource settings may not have timely access to accurate breast cancer diagnosis, impacting their overall treatment outcomes. The challenge of making core needle biopsy procedures more affordable and accessible remains a key issue that needs to be addressed to ensure equitable healthcare for all patients regardless of their geographic or economic status.
Challenge: Need for Skilled Professionals
One of the challenges in the breast cancer core needle biopsy market is the need for skilled professionals to perform the procedure. Core needle biopsy, particularly when guided by imaging techniques, requires a certain level of expertise and training. The accuracy of the biopsy significantly depends on the skill of the healthcare professional in correctly identifying and sampling the target lesion. This need for specialized training may limit the availability of core needle biopsy services, especially in regions lacking medical professionals with the requisite skills. Additionally, as new biopsy technologies and techniques are developed, there is a continuous need for ongoing training and education for medical staff. Ensuring that healthcare providers are up-to-date with the latest advancements in biopsy techniques is crucial for maintaining the high standards of diagnostic accuracy and patient care. This challenge highlights the importance of investing in medical education and training programs, particularly in regions with a shortage of skilled healthcare professionals.
Market Segmentation by Technology
In the breast cancer core needle biopsy market, segmentation by technology scope reveals a diverse range of imaging techniques, each playing a vital role in the diagnostic process. Among these, Ultrasound-based Breast Biopsy holds the highest revenue share, primarily due to its widespread availability, cost-effectiveness, and non-invasive nature. Ultrasound-guided biopsies are favored for their real-time imaging, lack of radiation exposure, and proficiency in sampling lesions that are palpable or visible on ultrasound. Meanwhile, the MRI-based Breast Biopsy segment is witnessing the highest Compound Annual Growth Rate (CAGR). This surge is attributed to MRI's superior imaging capabilities in detecting and characterizing breast lesions, especially in dense breast tissues where other imaging modalities might be less effective. MRI-guided biopsies are increasingly preferred for their high sensitivity in detecting small and otherwise occult breast cancers, making them invaluable in high-risk patient populations. Other technologies like Mammography-based (Stereotactic) Breast Biopsy and CT-based Breast Biopsy also play significant roles, with stereotactic biopsies being essential for sampling microcalcifications and CT offering detailed cross-sectional imaging. Each technology addresses specific diagnostic needs, contributing to the overall growth of the market.
Market Segmentation by End-Use
Regarding end-use scope, the market is segmented into Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Hospitals & Diagnostic Laboratories represent the segment with the highest revenue, owing to their primary role in patient diagnosis and treatment. The availability of diverse imaging modalities, coupled with the expertise of medical professionals in these settings, makes hospitals and diagnostic labs essential centers for breast biopsy procedures. These facilities are often the first point of contact for patients seeking breast cancer diagnosis and play a crucial role in the breast cancer care continuum. On the other hand, Academic & Research Institutes are projected to exhibit the highest CAGR. This growth is driven by the increasing focus on cancer research, including the development of new biopsy technologies and techniques. Research institutes are pivotal in advancing our understanding of breast cancer biology and diagnostics, often in collaboration with hospitals and industry players. Their role in training medical professionals and conducting clinical trials contributes significantly to the advancements in breast cancer diagnostics. Pharmaceutical & Biotechnology Companies also contribute to this segment, particularly through collaborations in drug development and personalized medicine research. These companies leverage biopsy data to understand tumor biology better, aiding in the development of targeted therapies. The synergy among these end-use segments underlines a comprehensive approach to breast cancer diagnosis and treatment, driving the overall growth of the breast cancer core needle biopsy market.
Regional Insights
In the geographic analysis of the breast cancer core needle biopsy market, distinct regional trends and variations in market dynamics are evident. As of 2023, North America held the highest revenue share, a position largely attributed to the advanced healthcare infrastructure, high breast cancer awareness levels, and the early adoption of innovative diagnostic technologies in this region. The well-established healthcare policies, along with the presence of leading healthcare companies and a strong focus on women's health, have been pivotal in driving the market in North America. Looking forward, from 2024 to 2032, the Asia-Pacific region is expected to exhibit the highest Compound Annual Growth Rate (CAGR). This anticipated growth can be attributed to the increasing awareness of breast cancer, improving healthcare infrastructure, and rising disposable incomes in countries like China and India. Moreover, the growing emphasis on early cancer detection and screening programs, coupled with the expanding healthcare sector in these emerging economies, is likely to drive significant growth in this region.
Analysis of Key Players
Regarding competitive trends and strategies, the breast cancer core needle biopsy market is characterized by a mix of established players and emerging competitors. As of 2023, companies such as Intact Medical Corporation, Ethicon Surgical Technologies, Gallini SRL, Leica BiosystemsNussloch GmbH, Hologic, Inc., Argon Medical Devices, Encapsule Medical Devices LLC, Cook Medical Incorporated, Becton, Dickinson and Company, C.R. Bard, Inc. led the market, mainly due to their strong product portfolios, extensive distribution networks, and ongoing R&D activities. These companies have focused on strategic partnerships, acquisitions, and product innovation to strengthen their market positions. For instance, Hologic has been instrumental in advancing breast biopsy technologies, particularly in the development of vacuum-assisted biopsy systems. BD's focus on enhancing needle accuracy and patient comfort has also been a critical factor in its market dominance. Moving into the forecast period from 2024 to 2032, these companies are expected to continue leading the market, but they will likely face increased competition from new entrants and regional players, particularly in the rapidly growing markets of Asia-Pacific. The market is also expected to see a surge in innovations, particularly in the development of less invasive, more accurate biopsy techniques and the integration of artificial intelligence for improved imaging and diagnostics. Furthermore, with the growing focus on personalized medicine, there is an increasing opportunity for collaboration between diagnostic companies and pharmaceutical firms to develop targeted therapies based on biopsy results. As the market evolves, there will also be an increased emphasis on addressing disparities in access to breast cancer diagnostics, particularly in underserved regions. This period is expected to witness a strategic shift towards more affordable and accessible diagnostic solutions, making early and accurate breast cancer detection a reality for a broader population worldwide.
Historical & Forecast Period
This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Breast Cancer Core Needle Biopsy market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Breast Cancer Core Needle Biopsy market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.
Market Segmentation
Technology Scope
- MRI-based Breast Biopsy
- Ultrasound-based Breast Biopsy
- Mammography-based (Stereotactic) Breast Biopsy
- CT-based Breast Biopsy
- Other Image Based Breast Biopsy
End-Use Scope
- Hospitals & Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
Region Segment (2022-2032; US$ Million)
North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Key questions answered in this report
What are the key micro and macro environmental factors that are impacting the growth of Breast Cancer Core Needle Biopsy market?
What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Breast Cancer Core Needle Biopsy market?
Which is the largest regional market for Breast Cancer Core Needle Biopsy market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Breast Cancer Core Needle Biopsy market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Breast Cancer Core Needle Biopsy market worldwide?
Table of Contents
1. Preface
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted
2. Executive Summary
- 2.1. Market Snapshot: Global Breast Cancer Core Needle Biopsy Market
- 2.2. Global Breast Cancer Core Needle Biopsy Market, By Technology Scope, 2023 (US$ Million)
- 2.3. Global Breast Cancer Core Needle Biopsy Market, By End-Use Scope, 2023 (US$ Million)
- 2.4. Global Breast Cancer Core Needle Biopsy Market, By Geography, 2023 (US$ Million)
- 2.5. Attractive Investment Proposition by Geography, 2023
3. Breast Cancer Core Needle Biopsy Market: Competitive Analysis
- 3.1. Market Positioning of Key Breast Cancer Core Needle Biopsy Market Vendors
- 3.2. Strategies Adopted by Breast Cancer Core Needle Biopsy Market Vendors
- 3.3. Key Industry Strategies
- 3.4. Tier Analysis 2023 Versus 2032
4. Breast Cancer Core Needle Biopsy Market: Macro Analysis & Market Dynamics
- 4.1. Introduction
- 4.2. Global Breast Cancer Core Needle Biopsy Market Value, 2022 - 2032, (US$ Million)
- 4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
- 4.4. Impact Analysis of Drivers and Restraints
- 4.5. See-Saw Analysis
- 4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
- 4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape
5. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 5.1. Market Overview
- 5.2. Growth & Revenue Analysis: 2023 Versus 2032
- 5.3. Market Segmentation
- 5.3.1. MRI-based Breast Biopsy
- 5.3.2. Ultrasound-based Breast Biopsy
- 5.3.3. Mammography-based (Stereotactic) Breast Biopsy
- 5.3.4. CT-based Breast Biopsy
- 5.3.5. Other Image Based Breast Biopsy
6. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 6.1. Market Overview
- 6.2. Growth & Revenue Analysis: 2023 Versus 2032
- 6.3. Market Segmentation
- 6.3.1. Hospitals & Diagnostic Laboratories
- 6.3.2. Pharmaceutical & Biotechnology Companies
- 6.3.3. Academic & Research Institutes
7. North America Breast Cancer Core Needle Biopsy Market, 2022-2032, USD (Million)
- 7.1. Market Overview
- 7.2. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 7.3. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 7.4.Breast Cancer Core Needle Biopsy Market: By Region, 2022-2032, USD (Million)
- 7.4.1.North America
- 7.4.1.1. U.S.
- 7.4.1.1.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 7.4.1.1.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 7.4.1.2. Canada
- 7.4.1.2.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 7.4.1.2.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 7.4.1.3. Rest of North America
- 7.4.1.3.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 7.4.1.3.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 7.4.1.1. U.S.
- 7.4.1.North America
8. UK and European Union Breast Cancer Core Needle Biopsy Market, 2022-2032, USD (Million)
- 8.1. Market Overview
- 8.2. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 8.3. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 8.4.Breast Cancer Core Needle Biopsy Market: By Region, 2022-2032, USD (Million)
- 8.4.1.UK and European Union
- 8.4.1.1. UK
- 8.4.1.1.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 8.4.1.1.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 8.4.1.2. Germany
- 8.4.1.2.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 8.4.1.2.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 8.4.1.3. Spain
- 8.4.1.3.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 8.4.1.3.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 8.4.1.4. Italy
- 8.4.1.4.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 8.4.1.4.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 8.4.1.5. France
- 8.4.1.5.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 8.4.1.5.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 8.4.1.6. Rest of Europe
- 8.4.1.6.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 8.4.1.6.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 8.4.1.1. UK
- 8.4.1.UK and European Union
9. Asia Pacific Breast Cancer Core Needle Biopsy Market, 2022-2032, USD (Million)
- 9.1. Market Overview
- 9.2. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 9.3. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 9.4.Breast Cancer Core Needle Biopsy Market: By Region, 2022-2032, USD (Million)
- 9.4.1.Asia Pacific
- 9.4.1.1. China
- 9.4.1.1.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 9.4.1.1.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 9.4.1.2. Japan
- 9.4.1.2.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 9.4.1.2.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 9.4.1.3. India
- 9.4.1.3.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 9.4.1.3.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 9.4.1.4. Australia
- 9.4.1.4.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 9.4.1.4.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 9.4.1.5. South Korea
- 9.4.1.5.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 9.4.1.5.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 9.4.1.6. Rest of Asia Pacific
- 9.4.1.6.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 9.4.1.6.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 9.4.1.1. China
- 9.4.1.Asia Pacific
10. Latin America Breast Cancer Core Needle Biopsy Market, 2022-2032, USD (Million)
- 10.1. Market Overview
- 10.2. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 10.3. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 10.4.Breast Cancer Core Needle Biopsy Market: By Region, 2022-2032, USD (Million)
- 10.4.1.Latin America
- 10.4.1.1. Brazil
- 10.4.1.1.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 10.4.1.1.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 10.4.1.2. Mexico
- 10.4.1.2.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 10.4.1.2.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 10.4.1.3. Rest of Latin America
- 10.4.1.3.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 10.4.1.3.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 10.4.1.1. Brazil
- 10.4.1.Latin America
11. Middle East and Africa Breast Cancer Core Needle Biopsy Market, 2022-2032, USD (Million)
- 11.1. Market Overview
- 11.2. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 11.3. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 11.4.Breast Cancer Core Needle Biopsy Market: By Region, 2022-2032, USD (Million)
- 11.4.1.Middle East and Africa
- 11.4.1.1. GCC
- 11.4.1.1.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 11.4.1.1.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 11.4.1.2. Africa
- 11.4.1.2.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 11.4.1.2.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 11.4.1.3. Rest of Middle East and Africa
- 11.4.1.3.1. Breast Cancer Core Needle Biopsy Market: By Technology Scope, 2022-2032, USD (Million)
- 11.4.1.3.2. Breast Cancer Core Needle Biopsy Market: By End-Use Scope, 2022-2032, USD (Million)
- 11.4.1.1. GCC
- 11.4.1.Middle East and Africa
12. Company Profile
- 12.1. Intact Medical Corporation
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
- 12.2. Ethicon Surgical Technologies
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
- 12.3. Gallini SRL
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
- 12.4. Leica BiosystemsNussloch GmbH
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
- 12.5. Hologic, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
- 12.6. Argon Medical Devices
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
- 12.7. Encapsule Medical Devices LLC
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
- 12.8. Cook Medical Incorporated
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
- 12.9. Becton, Dickinson and Company
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
- 12.10. C.R. Bard, Inc.
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives
- 12.11. Other Notable Players
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Portfolio
- 12.11.4. Strategic Initiatives
List of Tables
- TABLE 1 Global Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 2 Global Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 3 North America Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 4 North America Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 5 U.S. Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 6 U.S. Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 7 Canada Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 8 Canada Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 9 Rest of North America Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 10 Rest of North America Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 11 UK and European Union Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 12 UK and European Union Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 13 UK Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 14 UK Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 15 Germany Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 16 Germany Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 17 Spain Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 18 Spain Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 19 Italy Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 20 Italy Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 21 France Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 22 France Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 23 Rest of Europe Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 24 Rest of Europe Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 25 Asia Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 26 Asia Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 27 China Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 28 China Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 29 Japan Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 30 Japan Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 31 India Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 32 India Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 33 Australia Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 34 Australia Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 35 South Korea Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 36 South Korea Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 37 Latin America Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 38 Latin America Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 39 Brazil Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 40 Brazil Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 41 Mexico Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 42 Mexico Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 43 Rest of Latin America Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 44 Rest of Latin America Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 45 Middle East and Africa Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 46 Middle East and Africa Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 47 GCC Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 48 GCC Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 49 Africa Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 50 Africa Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
- TABLE 51 Rest of Middle East and Africa Breast Cancer Core Needle Biopsy Market By Technology Scope, 2022-2032, USD (Million)
- TABLE 52 Rest of Middle East and Africa Breast Cancer Core Needle Biopsy Market By End-Use Scope, 2022-2032, USD (Million)
List of Figures
- FIG. 1 Global Breast Cancer Core Needle Biopsy Market: Market Coverage
- FIG. 2 Research Methodology and Data Sources
- FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
- FIG. 4 Global Breast Cancer Core Needle Biopsy Market: Quality Assurance
- FIG. 5 Global Breast Cancer Core Needle Biopsy Market, By Technology Scope, 2023
- FIG. 6 Global Breast Cancer Core Needle Biopsy Market, By End-Use Scope, 2023
- FIG. 7 Global Breast Cancer Core Needle Biopsy Market, By Geography, 2023
- FIG. 8 Market Geographical Opportunity Matrix - Global Breast Cancer Core Needle Biopsy Market, 2023
FIG. 9Market Positioning of Key Breast Cancer Core Needle Biopsy Market Players, 2023
FIG. 10Global Breast Cancer Core Needle Biopsy Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
- FIG. 11 Global Breast Cancer Core Needle Biopsy Market, By Technology Scope, 2023 Vs 2032, %
- FIG. 12 Global Breast Cancer Core Needle Biopsy Market, By End-Use Scope, 2023 Vs 2032, %
- FIG. 13 U.S. Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 14 Canada Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 15 Rest of North America Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 16 UK Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 17 Germany Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 18 Spain Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 19 Italy Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 20 France Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 21 Rest of Europe Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 22 China Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 23 Japan Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 24 India Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 25 Australia Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 26 South Korea Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 27 Rest of Asia Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 28 Brazil Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 29 Mexico Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 30 Rest of Latin America Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 31 GCC Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 32 Africa Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
- FIG. 33 Rest of Middle East and Africa Breast Cancer Core Needle Biopsy Market (US$ Million), 2022 - 2032
